Login

Steven van Rijswijk, CEO of ING, discusses global business and market trends in an interview with CNBC at the World Economic Forum. 00:10:00

Share On Facebook Share On Twitter

Steven van Rijswijk, CEO of ING

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Jervois Mining Explores Nickel-Cobalt Potential at One-to-One Conference in Cape Town
00:00:00
Test target cancers that are difficult to diagnose - Panna Sharma, CEO, Cancer Genetics Inc
00:10:00
From Student Entrepreneurship Advocate to Leading Deep-Tech VC | Peter Hébert, Co-founder, Lux Capital.
00:10:00
AirAsia CEO Tony Fernandes on the Future of the Airline Industry and South Korea's Potential as a Hub | Tony Fernandes, CEO, AirAsia Bhd.
00:10:00
Steppe Gold: Expanding High-Grade Zinc and Gold Production in Mongolia
00:10:00
We focus on early-stage, transformative, deep tech start-ups solving complex enterprise challenges|Yuval Cohen,Founder and Managing Partner,StageOne Ventures
00:10:00
Odilon Almeida, CEO of ACI Worldwide, discusses the company's latest financial results and outlook for the coming months.
00:10:00
Find The Best Real Estate Solutions For You|Gary A. Pache,CEO,Camelot Group
00:10:00
Shoper Leads Poland’s E-commerce Software Market with Scalable SaaS and PAYG Models | Marcin KuĊ›mierz, President , Shoper SA.
00:00:00
Anna Ljung, CEO, Moberg Pharma AB (publ)
00:10:00
"Lazard Asset Management hosts an insightful summit on family offices and asset management, facilitating strategic discussions and networking opportunities."|Evan L. Russo became Chief Executive Officer of Lazard's Asset Management
00:00:00
Highlights Genetic Technologies (NASDAQ: GENE) -Simon Morriss, CEO, Genetic Technologies Ltd

© 2017 - Neuhu+